<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032022000100079</article-id>
<article-id pub-id-type="doi">10.35366/103562</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Toxoplasmosis cerebral: paresia del miembro superior única, una manifestación poco usual]]></article-title>
<article-title xml:lang="en"><![CDATA[Cerebral toxoplasmosis: paresis of the single upper limb, an unusual manifestation]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cajal Calvo]]></surname>
<given-names><![CDATA[Juan Ramón y]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sancho Saldaña]]></surname>
<given-names><![CDATA[Agustín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gimeno Peribáñez]]></surname>
<given-names><![CDATA[María José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Clínico Universitario &#8220;Lozano Blesa&#8221; Servicio de Radiodiagnóstico ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario Arnau de Vilanova Servicio de Neurología ]]></institution>
<addr-line><![CDATA[Lérida ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<fpage>79</fpage>
<lpage>82</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032022000100079&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032022000100079&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032022000100079&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La toxoplasmosis cerebral es una de las infecciones oportunistas más comunes en los pacientes con virus de inmunodeficiencia humana (VIH), siendo la principal causa de lesiones cerebrales en esta población originando secuelas neurológicas importantes y alcanzando una elevada mortalidad en este grupo de pacientes.  Caso clínico:  Paciente femenino que acude al servicio de urgencias con fiebre, cefalea, náusea y paresia del miembro superior izquierdo sin antecedentes médicos relevantes conocidos. Los estudios analíticos revelan unos niveles disminuidos de CD4+ y serologías positivas para VIH. Se estudió con el uso de métodos complementarios. La tomografía computarizada (TC) y la resonancia magnética (RM) mostraron imágenes compatibles con infección del tipo de la toxoplasmosis. Se realizó serología para el parásito que resultó positiva, dando el diagnóstico definitivo. Se trató con pirimetamina-sulfadiazina durante seis semanas.  Conclusión:  La toxoplasmosis cerebral es frecuente en pacientes con VIH, por lo que un diagnóstico temprano tanto del VIH como de la toxoplasmosis es indispensable para un tratamiento adecuado y evitar futuras comorbilidades.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Cerebral toxoplasmosis is one of the most common opportunistic infections in HIV patients, being the main cause of brain lesions in this population, causing important neurological sequelae and reaching a high mortality rate in this group of patients.  Clinical case:  A female patient came to the emergency department with fever, headache, nausea, and left upper limb paresis with no known relevant medical history. Laboratory studies reveal decreased CD4+ levels and positive serologies for HIV. It was studied with the use of complementary methods. CT and MRI showed images compatible with infection for toxoplasmosis. Serology was performed for the parasite that was positive, giving the definitive diagnosis. He was treated with pyrimethamine-sulfadiazine for a six-weeks.  Conclusion:  Cerebral toxoplasmosis is frequent in patients with HIV, so an early diagnosis of both HIV and toxoplasmosis is essential for adequate treatment, avoiding future comorbidities.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[VIH]]></kwd>
<kwd lng="es"><![CDATA[inmunosupresión]]></kwd>
<kwd lng="es"><![CDATA[toxoplasmosis]]></kwd>
<kwd lng="es"><![CDATA[cerebral]]></kwd>
<kwd lng="es"><![CDATA[paresia]]></kwd>
<kwd lng="en"><![CDATA[HIV]]></kwd>
<kwd lng="en"><![CDATA[immunosuppression]]></kwd>
<kwd lng="en"><![CDATA[toxoplasmosis]]></kwd>
<kwd lng="en"><![CDATA[cerebral]]></kwd>
<kwd lng="en"><![CDATA[paresis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunay]]></surname>
<given-names><![CDATA[IR]]></given-names>
</name>
<name>
<surname><![CDATA[Gajurel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dhakal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Liesenfeld]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Montoya]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice]]></article-title>
<source><![CDATA[Clin Microbiol Rev]]></source>
<year>2018</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e00057-17</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease]]></article-title>
<source><![CDATA[J Int Assoc Provid AIDS Care]]></source>
<year>2019</year>
<volume>18</volume>
<page-range>2325958219867315</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyons]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[McLeod]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxoplasma gondii tachyzoite-bradyzoite interconversion]]></article-title>
<source><![CDATA[Trends Parasitol]]></source>
<year>2002</year>
<volume>18</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>198-201</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parlog]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schluter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dunay]]></surname>
<given-names><![CDATA[IR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxoplasma gondii-induced neuronal alterations]]></article-title>
<source><![CDATA[Parasite Immunol]]></source>
<year>2015</year>
<volume>37</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>159-70</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mamidi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[DeSimone]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Pomerantz]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Central nervous system infections in individuals with HIV-1 infection]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2002</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>158-67</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Thota]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pellegrino]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pasupuleti]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Benites-Zapata]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
<name>
<surname><![CDATA[Deshpande]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?]]></article-title>
<source><![CDATA[HIV Med]]></source>
<year>2017</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selby]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Quesenberry]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case-control study of screening sigmoidoscopy and mortality from colorectal cancer]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1992</year>
<volume>326</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>653-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greenway]]></surname>
<given-names><![CDATA[MRF]]></given-names>
</name>
<name>
<surname><![CDATA[Sacco]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Burton]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In deep: cerebral toxoplasmosis]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2017</year>
<volume>130</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>802-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
